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In recent years, cell-penetrating peptides have proven to be an efficient intracellular delivery system. The mechanism for CPP internalisation,
which first involves interaction with the extracellular matrix, is followed in most cases by endocytosis and finally, depending on the type of
endocytosis, an intracellular fate is reached. Delivery of cargo attached to a CPP requires endosomal release, for which different methods have
recently been proposed. Positively charged amino acids, hydrophobicity and/or amphipathicity are common to CPPs. Moreover, some CPPs can
self-assemble. Herein is discussed the role of self assembly in the cellular uptake of CPPs. Sweet Arrow Peptide (SAP) CPP has been shown to
aggregate by CD and TEM (freeze-fixation/freeze-drying), although the internalised species have yet to be identified as either the monomer or
an aggregate.
© 2006 Elsevier B.V. All rights reserved.Keywords: Amphipathic peptide; Cell-penetrating peptide; Drug delivery; Internalisation mechanism; Self-assembly1. Introduction
Recent advances in genomics and proteomics have led to
numerous interesting new drug candidates of various types,
such as short oligonucleotides, plasmids, peptides or proteins.
Unfortunately, these compounds are unable to cross the cell
membrane, unless specific mechanisms have evolved with this
objective. Thus, carrier delivery methods have to be developed
to impart good bioavailability to these compounds. Different
approaches have been described to deliver drugs into cells (e.g.,
micro-injection, electroporation, freeze–thaw techniques, viral
delivery systems, liposomes or cationic lipids) but these⁎ Corresponding author. Institut de Recerca Biomèdica de Barcelona, Parc
Científic de Barcelona, Josep Samitier 1-5, E-08028 Barcelona, Spain. Tel.: +34
93 403 71 25; fax: +34 93 403 71 26.
E-mail address: egiralt@pcb.ub.es (E. Giralt).
0005-2736/$ - see front matter © 2006 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamem.2006.01.006methods suffer from problems such as low transfer efficiency,
complex manipulation, cellular toxicity or immunogenicity.
An alternative delivery method is the use of peptides able to
translocate the cell-membrane, these peptides are often referred
as cell-penetrating peptides (CPPs). Work in this area stemmed
from the discovery that the third helix of Antennapedia
homeodomain, pAntp(43–58), can cross biological membranes
[1]. Since then, different CPPs have been described to
efficiently deliver various types of cargo to the inside of cells,
from low molecular weight drugs to liposomes, plasmids,
antibodies or nanoparticles [2].
Initially, CPPs were defined as short cationic peptides able to
translocate through the plasma membrane of eukaryotic cells
via a receptor- and endocytosis-independent mechanism, but a
re-evaluation of the internalisation mechanism yielded a new
CPP concept. CPPs are peptides made of less than 30 amino
acids that are internalised via energy-dependent or independent
mechanisms. Positively charged amino acids, hydrophobicity
Table 1
Principal classes of CPPs with their characteristics
Name Sequence Length Net
charge
Kind of amphipaticity Aggregation? Internalisation
mechanism
Natural CPPs
Tat(48–60) a GRKKRRQRRRPPQ 13 8 Secondary
amphipathicity
Endocytic
Penetratin (pAntp(43–58)) RQIKIWFQNRRMKWKK 16 7 Partially secondary
amphipathicity
Yes Endocytic
MPG GALFLGFLGAAGSTMGAWSQPKKKRKV 27 5 Primary
amphipathicity
Independent
of endocytosis
SAP (Sweet Arrow Peptide) VRLPPPVRLPPPVRLPPP 18 3 Secondary
amphipathicity
Yes Endocytic
hCT(9–32)-br {[LGTYTQDFNK(&)FHTFPQTAIGVGAP]
[PKKKRKVEDPGVGFA&]} b
40 5 Endocytic
Artificial CPPs
Transportan GWTLNSAGYLLGKINLKALAALAKKIL 27 5 Yes Endocytic
MAP (Model Amphipathic
Peptide)
KLALKLALKALKAALKLA 18 5 Secondary
amphipathicity
Yes Independent
of endocytosis
pVEC LLIILRRRIRKQAHAHSK 18 8 Independent
of endocytosis
Pep-1 KETWWETWWTEWSQPKKKRKV 21 6 Primary
amphipathicity
Yes Independent
of endocytosis
Polyarginines Rn n n Unclear
a Amino acid sequence could vary with different studies.
b See reference [120] for the nomenclature system.
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the known CPPs (Table 1). CPPs also include peptides with
non-natural amino acids, such as β-amino acids [3] or γ-amino
acids [4,5], which have the advantage of being completely
stable to proteolytic degradation. Amino-acid based dendrimers
capable of crossing the cellular membrane [6] have also been
reported.
The development of efficient cell-penetrating peptide
vectors demands a precise understanding of the different
steps of the internalisation mechanism, the peptide structural
features required for every step and the type of cargo to be
delivered.
2. Internalisation mechanism
2.1. First step: interaction with the extracellular matrix
In the majority of cases, internalisation begins with
interactions between the CPP and the extracellular matrix,
requiring the capture of the CPP by cell-surface proteoglycans
(PGs). Proteoglycans, the plasma membrane carriers for the
majority of CPPs, are a heterogeneous group of proteins
substituted with long, linear, polysulphated and negatively
charged glycosaminoglycan (GAG) polysaccharides. Chondroi-
tin sulphate (CS), dermatan sulphate (DS) or heparan sulphate
(HS) are the most prevalent GAGs in PGs. These proteins
feature a common linkage region, GlcA–Gal–Gal–Xyl, where a
glycosidic bond is formed between the Xyl residue and a Ser
chain from the core protein. The GAG chain may be extended
by disaccharides consisting of either GlcA-β-GalNAc or GlcA-
α-GlcNAc. The anionic charge of the chains is the result of
sulphation reactions [7].Cell-surface heparan sulphate proteoglycans (HSPGs) are
divided into two families: the syndecans and the glypicans.
Syndicans are transmembrane HSPGs that are substituted with
either chondroitin sulphate or by heparan sulphate, and that
position the HS chain distal to the plasma membrane. On the
other hand, glypicans are linked through the plasma membrane
lipid via a glycosylphosphatidylinositol (GPI) anchor, wherein
the HS chains, which only contain HS, are positioned adjacent
to the plasma membrane [8,9].
Whether the CPP internalisation occurs via passive diffusion
or by endocytosis, it seems that the initial contact between most
CPPs and the cell involves the proteoglycans. These physio-
logical membrane constituents act as acceptors, or receptors, for
extracellular CPPs, ultimately leading to peptide uptake at
multiple sites of the cell surface (Fig. 1(1)).
Different methods have been used to study the role of HSPGs
in CPP uptake, including isothermal titration calorimetry
[10,11], ESR spectroscopy [12] and affinity chromatography
[13]. Furthermore, three kinds of in vitro studies have been
used: enzymatic degradation of extracellular HS chains,
competition with exogenous HS chains, and HSPG-deficient
mutant cells [7,14,15].
The first notion that cell-surface proteoglycans are implicat-
ed in the onset of Tat(48–60) internalisation arose from studies
done with the full-length Tat protein [14,16–18]. A study by
Silhol et al. [19] established that the internalisation mechanism
of full-length Tat protein involved HSPGs, even if it was fused
to GSTor GFP, but this dependence was not found in the case of
Tat(48–60) CPP. On the contrary, the majority of recent studies
argue for the involvement of HSPGs in the uptake of Tat(48–
60). Suzuki et al. [20] demonstrated that incubation of Tat(48–
60) with HS or CS-A, CS-B or CS-C – where A, B or C
Fig. 1. Different steps in CPP-mediated intracellular delivery. (1) Interaction of the CPP (represented as a green bar) with the cell-surface proteoglycans (in red). (2)
Endocytic pathway. (3a) Degradative route to lysosomes in clathrin-mediated endocytosis. (3b) CPP ultimately reach the Golgi apparatus (in purple) or endoplasmic
reticulum (ER, in grey) in caveolin-mediated endocytosis. (3c) Endosomal release.
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impaired its cellular uptake. The same was found for Arg8,
leading to the conclusion that the electrostatic interaction
between the sulphated polysaccharides and the Arg-rich
peptides plays a crucial role in cell membrane penetration.
Working with biotinylated CPP complexed with strepta-
vidin or avidin, it was found that coincubation with heparin
inhibited internalisation by 60–70% in the case of Tat(46–
56) and 40–50% for Antp(43–58) [21]. On the other hand,
dextran sulphate inhibited the uptake of Tat(46–56) complex
but not that of Antp(43–58) complexes, while CS-A, CS-B,
CS-C and hyaluronic acid had no effect on the uptake of Tat
(46–56) or Antp(43–58) complexes. Moreover, the com-
plexes were not internalised into mutant CHO cells deficient
in GAGs.
The internalisation of Arg9 labelled with TAMRA fluores-
cent marker was completely impaired for the case of two mutant
CHO cell lines: CHO-pgsD-677, which do not produce HS, and
CHO-pgsA-745, which produce neither HS nor CS [13]. The
same effect was seen when adding exogenous heparin to the
culture medium. Calorimetric studies also support a strongaffinity of Arg9 for HS, with binding stoichiometries close to
charge neutrality.
For penetratin (pAntp), the internalisation was favoured in
cells expressing α-2,8-polysialic acid (PSA) at their surfaces,
although the internalisation was not blocked in cells that do not
express PSA [22,23].
Apart from Tat, pAntp and polyarginines, there are other
CPPs in which the initial cell-surface interaction is via HSPGs.
Recently, it has been shown that the internalisation levels of
hCT(9–32)-br and SAP (Sweet Arrow Peptide) are decreased if
heparin is added to the cell culture medium [24]. As expected,
the decrease is directly proportional to the number of positive
charges.
The primary interaction between the Arg-rich CPPs and
HSPGs is electrostatic, but it is also likely that hydrogen
bonding occurs, taking into account the ability of the
guanidinium group to form hydrogen bonds with sulphate and
carboxylate groups [25–28] (Fig. 2).
Interestingly, a common peptidic motif has been found for
interactions with HSPGs, consisting of basic amino acids
flanked by hydrophobic residues. The sequences BBXB and
Fig. 2. (a) Interaction of the guanidinium group with sulphates and carboxylates. (b) Structure of heparan sulphate.
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amino acid – have been reported [29,30].
Moreover, it has been described that the binding of a ligand
to HSPGs induces aggregation and ligand clustering, such that
CPPs are concentrated at the cell surface for subsequent
internalisation [11,31]. Recently, these aggregates have been
visualised using differential interference contrast CLSM for Tat
(46–56) incubated with mouse fibroblasts [31]. If HS is added
afterwards, dark aggregates corresponding to the self-assembled
peptide disappear from the cell surface appearing in the cell
culture medium. When HS is added at the same time as Tat(46–
56) CPP, aggregates are not formed at the cell surface, thereby
preventing the uptake of Tat(46–56).
Cell-surface HSPGs are known to enter the cell by
endocytosis and to be degraded in lysosomes as a major route
of turnover [32]. Interestingly, GPI-anchored proteins of
glypicans are associated with sphingolipid and cholesterol-
rich plasma membrane domains, such as those involved in
caveolin-mediated endocytosis [8].
Consistently, after the cell-surface HSPGs have captured the
CPP and promoted its concentration at the cell surface, three
different mechanisms can follow: direct membrane penetration
(the CPP–HSPG complex is enzymatically cleaved and passes
directly through the plasma bilayer to the cytoplasm), classical
endocytosis or caveolar endocytosis [8].
The binding of CPPs to the cell-surface through negatively
charged sulphates or carboxylates has sparked the idea thatCPPs internalisation is simply a matter of cell-membrane
recycling. More precisely, the CPP attaches to the cell surface
and exploits inherent cell-membrane turnover to be internalised
[33]. This would be similar to CPP internalisation kinetics, as
the cell plasma membrane is described to be renewed very
frequently. Concretely, ca. 2–5% of a cell-membrane is recycled
every minute [34,35].
The CPP–HSPG interaction is not permanent. Fuchs et al.
[13] argued that once the CPP is trapped inside an endosome,
the affinity of the interaction between the CPP and HSPGs
diminishes because cleavage of HS from the core protein by
heparanases causes a decrease in its anionic charge. The
resultant released peptide is thus “free” inside the endosome.
The interaction between HSPGs and CPPs was recently
exploited to create Vectocell® peptides, a new family of CPPs
derived from known heparin binding proteins [36]. Among the
different peptides generated, DPV3 has shown the greatest
internalisation level, with an even greater value than that for Tat
CPP.
Interestingly, another type of drug carrier, cationic lipid
reagents (e.g., Lipofectamine or Transfectan), also require cell-
surface PGs for optimal transfection efficiency [37–39].
2.2. Second step: translocation through the cell membrane
It was initially thought that CPPs were internalised via a
rapid, receptor- and endocytosis-independent mechanism,
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[1,20,40–44]. However, it was ultimately discovered that the
fluorescence diffuse pattern observed by CLSM was an artefact
of the cell fixation protocol, which caused an artificial
redistribution of the CPP [45]. Moreover, when quantifying
CPP uptake by flow cytometry, another kind of artefact was
incurred: as flow cytometry does not discriminate between
membrane-adsorbed or internalised peptide, it was found that a
step to remove the peptide attached to the membrane is needed
to avoid overestimation of internalisation [45]. Working with
unfixed cells, it was observed that Tat(48–60) and Arg9
colocalised with transferrin receptor and the endocytic marker
FM 4–64, leading to the conclusion that endocytosis could play
a role in internalisation. Furthermore, the uptake of both
peptides was blocked when the temperature was decreased to 4
°C, or the intracellular level of ATP was depleted using sodium
azide and 2-deoxy-D-glucose [45].
Since then, numerous studies have been undertaken to re-
examine the internalisation mechanism of CPPs, using live cells
instead of fixed cells. In the majority of these experiments,
endocytosis has been identified as the most probable pathway
for the cellular uptake of CPP (Fig. 1(2)) [13,21,46–50].
The fact that polyarginines, Tat(44–57) or Antp(43–58), are
not able to penetrate through lipid bilayers or liposomal
membranes may be proof against passive diffusion and in
favour of the endocytic mechanism [11,46,51,52]. However,
studies claiming the direct passage of polyarginines through the
cytosolic membrane in the membrane potential direction have
also been reported [53].
In observing in vivo cells by CLSM, two different patterns
are found for Tat CPP, Antp and polyarginines: a diffuse and a
punctate pattern [49]. Some authors maintain that the observed
diffuse fluorescence comes from endocytic release to the
cytoplasm and nucleus, but the majority claim that the two
patterns found are due to different internalisation mechanisms.
Potocky et al. [54], observing by confocal microscopy the
pattern of internalisation of Tat(47–57), found three different
internalisation patterns: those with punctuate fluorescence,
others with a combination of punctate and diffuse fluorescence,
and still others with only diffuse fluorescence, located in the
cytoplasm and the nucleus. Strikingly, the fluorescence
distribution was concentration-dependent, being mainly punc-
tate at low concentrations of Tat(47–57) and having its highest
ratio of diffuse fluorescence at higher concentrations. Again, Tat
(47–57) colocalised with transferrin, and was not taken up in
the presence of sodium azide and 2-deoxy-D-glucose. Thus, it
was believed that the uptake was mainly endocytic. The authors
argued that the diffuse fluorescence observed was a conse-
quence of endosomal escape. To prove this hypothesis, they
coincubated the peptides with ammonium chloride, a weak base
that increases the pH of acidic organelles, including endosomes.
After coincubation, Tat(47–57) was only found in endosomes.
It was therefore concluded that changes in pH can alter the
conformation of the peptide or the formation of its aggregates,
thereby enabling it to cross the endosomal membrane.
Re-evaluation of the uptake mechanism for polyarginines
was demonstrated with octaarginine. It was shown that theinternalisation in fixed cells had a diffuse pattern in the
cytoplasm and nucleus, whereas without the fixation protocol
the peptide was found in cytoplasmic vesicular structures.
Moreover, the uptake was significantly reduced at 4 °C, as
judged by flow cytometry analysis [55].
To distinguish between cytoplasmatic or vesicular inter-
nalised CPP, two approaches have been used. The first, by Zaro
and Shen [56], uses a novel subcellular fractioning method to
separate vesicular versus cytoplasmatic compartments, allowing
differentiation between endocyted or directly translocated CPP.
In CHO cells, YG(1-R)9 and Tat CPP were mainly translocated
(18% and 8%, respectively) while YG(1-K)9 was mostly
endocyted. The authors concluded that membrane translocation
requires the guanidinium group of arginine, whereas endocy-
tosis only requires positive charges [56].
Another method for distinguishing between diffuse and
punctate internalised CPP is the use of an image analysis
algorithm that can quantify fluorescence that originates from
cellular vesicles [57]. The granularity algorithm has been used
to calculate the mean fluorescence per granule as well as the
number of fluorescent granules per cell. The resultant
distribution pattern varied with the cell line used and the
temperature. For pAntp, the pattern was mostly vesicular for the
two cell lines used in the study, however, at 4 °C, there was no
visible amount of punctate staining. It was thus concluded that
for pAntp, the uptake was mainly endocytic. For R7 and R7W, a
mixture of diffuse and punctate pattern was observed at 37 °C,
whereas at 4 °C no punctate staining was observed. However,
once peptidic cargo was attached to the CPP, the uptake pattern
was almost completely punctate.
This later aspect is frequently observed; the attachment of
large macromolecules often alters the internalisation mecha-
nism. The kinetics of cellular uptake have been shown to be
dependent on the size of the cargo attached to the CPP [19,36]:
when a high molecular weight cargo is attached, the uptake
occurs via endocytosis.
Great effort has been made to characterise the interaction
between CPPs and lipids, the main components of the cell-
membrane. It was initially thought that the first contact with the
cell-surface was due to an electrostatic interaction between the
positively charged residues of the CPP and the negatively
charged phospholipid head groups. But, in addition to results
from in vitro experiments, calorimetric studies demonstrate that,
at least for Arg9 and Tat CPP, the affinity for HS is greater than
that for anionic lipid vesicles [10,11,52]. As the first contact is
primarily with cell-surface proteoglycans, two options arise for
CPP–lipid interaction: if the peptide can insert itself into lipid
bilayers, the lipid–CPP bond could be useful for more tightly
attaching the CPP to the cell-surface, whereas if the peptide can
penetrate a lipid bilayer, endosomal release could be achieved
[11,13].
The lipidic composition of the cell-membrane seems to be an
important factor in the translocation process; CPP is taken up
into mammalian cells far more efficiently than into plant
protoplasts [58]. The internalisation of transportan, penetratin or
pVEC into Bowes human melanoma cells was significantly
greater than that into N. tabacum cv. SR-1 protoplasts. The
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composition of the cell-membrane: the sterol present in
mammalian cells is cholesterol, whereas plant cells have
sitosterols, stigmasterols and campesterols. Also, the respective
glycerolipid fatty acid chains are different, with stearic and
arachidonic acids in mammalian cells, and linoleic and linolenic
acids in plant cells.
Endocytosis has different regulated gates of entry into the
cell, which can initially be divided in two main categories:
phagocytosis (cell eating) or pinocytosis (cell drinking) [59,60].
Phagocytosis takes place only in specialised mammalian cells,
however, pinocytosis occurs in all cells by four different
mechanisms: macropinocytosis, clathrin-mediated endocytosis,
caveolin-mediated endocytosis or lipid-rafts (i.e., clathrin- and
caveolin-independent endocytosis). The kind of endocytosis
may depend not only on the CPP but also on the type of cargo
attached to it.
For Tat peptide, two different mechanisms have recently
been described: caveolin-mediated endocytosis and macro-
pynocitosis [61,62]. A GST-Tat-EGFP construct (using only
the CPP region of Tat) was internalised through caveolae as
proven by slow kinetics of internalisation, endosome-
resistant treatment to Triton X-100, colocalisation with
caveolin-1 and cholera toxin, and an internalisation sensitive
to drugs that reduce lipid raft formation (cyclodextrin or
cytochalasin D) [47,61]. Internalisation via caveolae is a
favourable pathway for drug delivery as it is non-acidic and
nondigestive.
On the other hand, the fusogenic Tat(CPP)-Cre protein was
found to colocalise with the endocytic marker FM4-64, to be
sensitive to cholesterol depletion and to not colocalise with
caveolin-1, thus imputing macropinocytosis as the internalisa-
tion mechanism followed [62].
The fact that R8 internalised less when incubated with the
macropinocytosis inhibitor 5-(N-ethyl-N-isopropyl)amiloride
proved that at least a fraction of the peptide is internalised via
said mechanism [55]. Similar experiments were performed for
penetratin, showing that macropinocytosis plays a minor role in
its uptake.
For hCT(9–32)-br and SAP CPPs it has been shown that the
internalisation takes place via lipid-rafts, as clear colocalisation
with cholera toxin was observed and the uptake was decreased
in the presence of the cholesterol-sequestering agent methyl-β-
cyclodextrin [24].
It is also important to note that enantio versions of CPPs have
been shown to translocate the cell-membrane, thus pointing to a
receptor-independent mechanism [1,63,64].
2.3. Third step: CPP intracellular pathway
Cellular internalisation mechanisms determine the cell-
compartment destination. Clathrin-mediated endocytosis
implies that the degradative route is followed, from early
endosomes to late endosomes, and ultimately to lysosomes (Fig.
1(3a)). On the other hand, if the caveolin-mediated route is
taken then the vesicles are targeted either to the Golgi apparatus
or to the endoplasmic reticulum (ER) (Fig. 1(3b)) [65].Moreover, when the vesicles are first directed to the Golgi, a
retrograde transport to the ER exists.
Fischer et al. [49] have suggested that cationic CPPs enter the
cytoplasm through a retrograde transport. Working with
brefeldin A and with nordihydroguaiaretic acid (NDGA),
which interfere with the integrity of the Golgi and the trans-
Golgi network, they found that the cellular uptake of R9 and
Antp was diminished considerably. In the case of Tat, its
fluorescence was reduced by brefeldin A but increased with
NDGA. Moreover, they observed partial colocalisation with the
cell-permeable Golgi-tracer Bodipy ceramide for Tat and Antp
peptides. These CPPs did not traffic into lysosomes as
confirmed by an absence or near-absence of colocalisation
with Lysotracker, an acidic compartment-specific probe.
2.4. Intracellular drug release: endosomal escape
As the principal internalisation mechanism is endocytosis, it
seems that most of the cell-penetrating peptides are not able to
directly translocate through membranes; they somehow interact
with, or insert into, the cell-membrane, thereby triggering the
endocytic machinery. As CPPs eventually become trapped in
the endosome, an escape route to the cytoplasm must be
exploited before the onset of lysosomal activity so that the cargo
can be released in the cytosol to exert its biological effects
(Fig. 1(3c)).
Different approaches to endosomal escape have been
suggested, from acid labile bonds to endosome-disrupting
peptides or laser triggered endosome aperture.
It is known that there is a decrease in vesicular pH during
endosomal trafficking, from approximately 7.4 to 5.0, suggest-
ing the use of acid-sensitive linkers to release the cargo
covalently bound to the peptide. This strategy was first
described for a model peptide, neuropeptide Y (NPY), which
has receptors expressed in neuroblastomas [66]. Upon compar-
ison of two daunorubicin-NPY conjugates having either a stable
amide bond or an acid-sensitive hydrazone linker, only the
former was found to be active. Afterwards, this strategy was
successfully applied in the case of hCT(9–32) also linked to
daunorubicin to achieve similar results [67].
Another proposed strategy is the use of endosome-disrupting
peptides. The 20 amino acid N-terminal region of the influenza
virus hemagglutinin protein, HA2, is used for this purpose, as it
is able to destabilise lipid membranes at low pH [62]. It was
used to asses the Tat-Cre mediated recombination, whereby an
increase in recombination was found when Tat-HA2 was added
to Tat-Cre, suggesting that greater release into the cytoplasm
had occurred [62]. Another endosome-disrupting peptide is 43E
peptide (LAEL–LAEL–LAEL), which disrupts endosomes via
a conformational change from a random coil at pH 7.4 to an α-
helix at pH 5.0 [68]. Adding 43E peptide to a mixture of 46 (a
cationic amphiphilic CPP) and plasmid DNA encoding firefly
luciferase led to a remarkable increase in transfection level.
Endosomal release of a cargo peptide fused to a fluorescently
labelled CPP by laser illumination has recently been reported
[69]. The release is thought to occur as a result of damage
caused by short-lived oxygen species generated by the applied
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as a phototrigger to induce endosomal escape. The photochem-
ical endosomal opening is a relatively non-cytotoxic treatment,
as proved by the observed biological response after laser
irradiation and the retained cell morphology 24h after treatment.
Currently, the majority of in vitro experiments for disruption
of endosomal membranes imply the use of chloroquine or
sucrose. These compounds neutralise the endosomal pH,
thereby blocking the transfer of peptide to late endosomes.
However, this method is not feasible from a therapeutic point of
view since the compounds lack membrane specificity, and
problems in the co-administration could arise.
Once the endosomal release is achieved, another problem
may emerge if the cargo is covalently bond to the CPP. If the
cargo linked to the CPP is unable to carry out its biological
activity, then the need to cleave the cargo from the CPP arises.
This problem can be solved if the peptide and cargo are
connected via a disulphide bond: upon arrival in the cytoplasm,
the CPP-cargo bond rapidly is cleaved by the action of
cytoplasmic glutathione.
3. Common features among CPPs and relevance to the
different internalisation steps
3.1. Positively charged amino acids
A feature shared among CPPs is a high degree of positive
charges, due to their content of the basic amino acids lysine and
arginine. It has been postulated that this characteristic is
important for the initial step of internalisation, the previously
explained interaction of cell-surface proteoglycans with sul-
phate groups. Positively charged amino acids may also be
important for the subsequent interaction of the CPP with the
nearby phosphate heads of the membrane lipids. At physiolog-
ical pH, both lysine (pKa, 10.5) and arginine (pKa, 12) are
protonated, and hence interact with negatively charged sulphate
and phosphate groups of the extracellular cell matrix. However,
it must be taken into account that due to the pKa difference
between lysine and arginine, K-rich peptides suffer partial
deprotonation, whereas R-rich peptides have to scavenge anions
in order to minimise charge repulsion [70–72].
A study comparing different homopolymers of arginine and
lysine established that those with arginine were highly
internalised [73], therefore, the guanidinium headgroup was
believed to be the crucial structural component for the
internalisation. This idea was further supported by the fact that
homopolymers of citrulline, which has a urea instead of a
guanidiniummoiety, are not internalised. Thus, it was concluded
that the special ability of the guanidinium group to form
bidentate hydrogen bonds with phosphate or sulphate groups
was the key (Fig. 2). The number of arginines required for
optimal cell-penetration in polyarginines seems to be between 7
and 15, depending on the techniques and the cell line used [56].
The crucial role of the guanidinium head group in
translocation has been assessed, since modifications in the
amino acid side chain, peptide backbone or linearity of the
oligoarginines do not seriously affect cellular internalisation.To establish the importance of the backbone, a series of
polyguanidine peptoid derivatives were synthesised, preserving
the 1,4-backbone spacing of arginine side chains but having an
oligoglycine backbone without stereogenic centers. These
molecules were taken up only slightly less than the corres-
ponding D-arginine peptides, suggesting that the hydrogen
bonding properties of the peptide backbone do not seem to be
important for cellular uptake [74]. Also, peptoid derivatives
with different numbers of methylene groups in the side chain
were synthesised. Those having longer side chains were taken
up to a greater extent. To distinguish between the possible
contributions of the hydrophobicity of the methylenes or the
flexibility of the side chain on the internalisation rate, peptoid
derivatives containing cyclohexyl side chains were prepared.
As the uptake was lower when the degrees of freedom
decreased, the conformational flexibility of the linear alkyl
chain appeared to be important for cellular uptake. Further
evidence that the backbone is not essential for translocation is
that a series of guanidine-rich oligocarbamates were able to
rapidly cross the cell membrane, even faster than the
polyarginines of the same length [75]. Therefore, the backbone
is only a scaffold which serves to expose the guanidinium
groups.
The linear structure of the arginine-rich peptides is also of no
importance to translocation, as a series of branched-chain
arginine-rich peptides have been shown to translocate the cell
membrane very efficiently [6,76].
Nevertheless, it is surprising that a highly cationic molecule
can so efficiently cross the cell membrane. Some light on this
matter has emerged from a study by Rothbard et al. [77]. Once
the positive charges are neutralised from the interaction with
anionic cell-surface groups, the less polar ion pair complex can
cross the cell membrane. To support this hypothesis, the
octanol/water partitioning of octaarginine in the absence or
presence of a fatty acid salt (sodium laureate) was studied.
Whereas the peptide alone stayed at the water layer, it moved
into the octanol layer upon addition of the fatty acid salt
(N95%). Surprisingly, ornithine oligomers in the presence of the
fatty acid salt stayed in the aqueous layer, again underlying the
importance of the guanidinium moiety and its capacity to form
effective bidentate hydrogen bonds. This was further supported
by checking the uptake capacity of mono- or dimethylated
arginine oligomers, in which the uptake was reduced by 80%
and more than 95%, respectively.
Apart from polyarginines, most CPPs contain arginine,
including Tat, penetratin, 46, pVec, SynB peptides and SAP.
In the case of SAP, three different positively charged amino
acids were chosen to modify the hydrophilic face of the
amphipathic PP II helix: His, Lys and Arg. Peptides bearing Arg
proved to be the most efficiently internalised by plate
fluorimetry and CLSM [78].
Individual substitutions of the Tat(49–57) cationic residues
by alanine caused a 70–90% decrease in cellular uptake [74].
Furthermore, Vives et al. working with variants of Tat(48–60)
in which the positively charged amino acids were deleted or
substituted, observed that translocation activity was indirectly
proportional to charge level [79].
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group of arginine is more effective for cell-uptake than other
positively charged groups there is one report against this idea.
Experiments have been performed in which large macromole-
cules with different lengths of arginine or lysine homopolymers
were delivered to various cell lines. The biotinylated peptides
were complexed with streptavidine and the 8 or 10 residue long
polylysines proved to be the most effective in the transduction
of the complex [15].
Also, a series of publications have made use of oligolysine
tails to promote the uptake of various oligonucleotide analogues
[80,81].
It is worth noting that, apart from being an essential feature
for membrane translocation, positive charges are very useful for
non-covalently binding negatively charged cargo (e.g., DNA or
RNA).
Even oligoguanidinium vectors, non-peptidic molecules that
bear the guanidinium moiety, have been described as very
efficient carriers [28]. Nonhydrolysable tetraguanidinium com-
pounds, formed by highly preorganised chiral bicyclic guanidi-
nium subunits linked through thioether spacers, underwent more
efficient cell-membrane translocation than Antp or Tat CPPs.
Interestingly, these cell-penetrating vectors, bearing an array of
highly basic guanidine groups, are able to reach mitochondria.
3.2. Hydrophobicity
Hydrophobicity is another common feature shared among
the majority of CPPs. It was initially thought that this
characteristic was essential for the interaction with the lipidic
part of the cell-membrane, but its function became unclear upon
discovery of the role of HSPGs in the first internalisation step.
The cellular uptake of penetratin has been described to be
dependent on the presence of a central hydrophobic core (W6,
F7). Substitution of the two tryptophan residues of penetratin
(positions 48 and 56) with phenylalanines did not lead to
significant differences in cellular uptake in unfixed cells [48],
whereas in fixed cells, it was observed that this substitution
prevented translocation of the peptide [1,82].
For Tat peptide, the attachment of a small hydrophobic
molecule, biotin, to the peptide caused a 6-fold increase in
cellular uptake [83]. In addition, insertions of aminocaproic acid
groups in the peptide backbone led to a stronger cell-association
[84].
A family of carrier peptides based on the hydrophobic core
(H region) of a signal peptide has been described to be
efficiently internalised in HEL cells [85–88]. The peptides
included two different sequences: one derived from Kaposi
fibroblast growth factor (AAVALLPAVLLALLAP) and the
other from integrin β3 (VTVLALGALAGVGVG).
Upon varying the content of hydrophobic Leu and hydro-
philic Lys amino acids in Hel amphipathic peptides, it was found
that the peptide with the highest proportion of hydrophobic
amino acids, Hel 13-5 (KLLKLLLKLWLKLLKLLL), was the
most efficient at delivering DNA [89]. It was also determined
that the hydrophobic region is important for the formation of
aggregates when delivering non-covalently DNA. It was thenhypothesised that the aggregate state may be important both for
cellular-uptake and for preventing DNA degradation. Moreover,
the hydrophobic amino acids were needed for stabilising the α-
helical structure.
Another example of the importance of hydrophobicity is the
lipophilisation at the N-terminus of mastoparan (MS, INLKA-
LAALAKKIL) or α-helix model peptide (HM, LARLLARL-
LARL) [90]. In the case of MS, it was modified with a single
acyl chain, a dialkylcarbamoyl group or a cholesteryloxycarbo-
nyl group, whereas HM was only modified with an acyl group
having a single chain. These modifications stabilised the α-
helical structure and the self-assembly with a defined number of
monomers. Gene transfer efficiency results revealed that in the
presence of chloroquine, some MS and HM lipophilic
derivatives were able to deliver DNA plasmids even more
efficiently than Lipofectin, reaching or even surpassing its
levels of internalisation.
Polyarginines were also modified with hydrophobic moieties
rending an improved CPP version [91]. Octaarginine was
lipophilised at the N-terminus with a stearyl, lauryl or cholesteryl
group, and it was observed that the derivative bearing the stearyl
group had the best transfection efficiency properties, improving the
octaarginine internalisation level by 2 orders of magnitude, and
reaching the levels of Lipofectamine. This effect was also observed
for Tat(48–60), as the stearylated derivative was 2 orders of
magnitude higher in gene transfection. Using dynamic light
scattering it was determined that the complexes of stearyl-
octaarginine with plasmid DNA form large aggregates compared
with octaarginine or lipofectamine alone. In this case the authors
argue that the hydrophobic moiety is mainly positioned on the
outside of the aggregate, contributing to the absorption of the
complex into the cell-membrane. It is also explained that the
complexes with the stearyl moiety are stabilised, by both
hydrophobic and ionic interactions, producing a positively charged
complex that could better interact with cell-surface [92].
Furthermore, chloroquine treatment generated similar results,
hence the authors believe that the octaarginines conjugated with
hydrophobic moieties are able to disrupt endosomes.
The uptake of SAP was improved when it was coupled to
caproyl or myristyl fatty acyl groups, especially in the case of
the latter, which has the longer chain [93]. Interestingly, only
this SAP derivative was found to interact with neutral DOPC
monolayers.
As there are CPPs composed exclusively of polar residues,
such as polyarginines and polylysines, it would seem that
hydrophobic moieties are not essential for translocation.
However, recent evidence argues against this notion. The
importance of hydrophobicity, in the presence of a fluorophore,
was recently highlighted in polyarginine uptake experiments
[94]. Normally, the comparison of the cellular uptake between a
peptide with or without a fluorophore cannot be made because a
fluorescent label is required to quantify peptide internalisation,
but in this study, the authors used 19F-NMR instead of the
common fluorescent techniques. The fluorescently-labelled
peptide had a greater affinity for the cell membrane as
compared to that of the non-labelled peptide. The authors
argue that the fluorescent label acts as an anchor to the cell
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and providing the peptide entry into the cell.
For all of the aforementioned reasons, it is believed that in
addition to electrostatic and hydrogen bonding interactions,
hydrophobic interactions also play a key role in CPP uptake.
In the case of non-peptidic cell-penetrating vectors, the
importance of hydrophobicity has also been reported. A
tetraguanidinium compound with a tert-butyldiphenylsilane
group (TBDPS) placed at one terminus of the tetraguanidinium
chain was 4-fold more efficient in translocation than the same
vector without this moiety [28].
3.3. Amphipathicity
A consequence of having both hydrophilic and hydrophobic
amino acids is that many CPPs are amphipathic.
In the context of peptides, the amphipathicity may result from
the primary or secondary structure [95]. Peptides with primary
amphipathicity are assembled from a hydrophilic and a hydro-
phobic region which are normally divided by a spacer domain.
On the other hand, secondary amphipathicity is achieved when
the peptide conformation is such that all of the polar residues
point to one side and the non-polar ones to the opposite side.
Two main groups of primary amphipathic peptides have
been described: signal peptides (SP) and fusion proteins (FP).
As a hydrophobic sequence, the SP family contains deri-
vatives of the SP Ig(v) 40 light chain of Caiman crocodylus
(MGLGLHLLVLAAALQGA), whereas the FP family con-
tains analogues of the gp41 fusion protein of HIV1
(GALFLGFLGAAGSTMGA). As a hydrophilic domain,
both families contain the nuclear localisation sequence of
the large T-antigen of SV40 (PKKKRKV). The SP family has
proven to be effective in the delivery of covalently linked
porphyrins [96] and oligonucleotides [97,98] and also of
complexed RNA or DNA [98]. DNAs encoding β-galactosi-
dase or luciferase and antisense DNA have been internalised
with CPPs from the FP class [99]. Another efficient CPP
having primary amphipathicity is Pep-1 [100–102], for which
this characteristic has been postulated to be responsible for its
strong interaction with lipidic membranes [103].
CPP amphipathicity as a result of secondary structure has
been reported in many examples, which can be divided into two
main groups: secondary amphipathicity due to α-helical
conformation or secondary amphipathicity from PP II structure.
Tat(47–57) and Antp(43–50), peptides derived from the
membrane destabilising peptide JST-1 and MAPs are examples
of the first class. The modelled structure of Tat(47–57) was
shown to be an amphipathic helix, with hydrophobic residues
pointing to one side of the helix and the hydrophilic ones
pointing to the other face [104]. Moreover, when three positions
of the peptide were substituted by α-helical promoting Ala, a 5-
fold internalisation increase was reached. Strikingly, when the
content of Ala residues was expanded to six and the Arg limited
to three, the improvement in uptake was 33-fold.
The region 43–50 of Antp(43–58) is strongly folded in an α-
helical structure, but there is also a minor conformer with the N-
t and the C-t regions in an extended conformation [105].Surprisingly, this extended conformation permits the formation
of aggregates. The content of α-helix conformation increases as
the environment approaches that of a cell-membrane (water,
perfluoro-tert-butanol and SDS). An analogue with Pro in
position 50 [Pro50]pAntp also adopts the α-helical structure
and is internalised in cells, but in contrast to the parent CPP
sequence, does not show conformation dependence on the
media [40]. A cyclic version of Antp did not exhibit cellular
uptake, denoting the importance of peptide conformation for
internalisaton and as well as for amphipathicity.
Other peptides with secondary amphipathicity due to an α-
helix conformation are ppTG1 (GLFKALLKLLKSLWKLLLKA)
and ppTG20 (GLFRALLRLLRSLWRLLLRA), derived from
the membrane destabilising acidic peptide JST-1, in which the
glutamic acid residues are substituted by Lys or Arg, respect-
ively. These CPPs are able to adopt an α-helical conformation,
show membrane destabilising properties (as assessed by the
liposome leakage assays) and also DNA-binding and gene
transfer abilities [106]. It is worth noting that the in vitro gene
transfer ability of ppTG1 is in the same range as other
commercial available transfection reagents, such as the cationic
lipid Lipofectin or the dendrimer Superfect. The authors claim
that there is a correlation between peptide conformation,
liposome leakage and gene transfer efficiency, as a derivative
with the leucines replaced by valines, ppTG30, adopted a β-
sheet structure and was not able to induce liposome leakage or
to efficiently deliver plasmid DNA.
To study the influence of amphipathicity in cellular uptake, a
series of derivatives of model amphipathic peptide (MAP) were
developed [107]. Detecting uptake by HPLC, it was initially
established that amphipathicity was crucial for internalisation
[108,109] but afterwards, using an online protocol for confocal
laser scanning microscopy including a washing step, it was
shown that amphipathicity is not essential, as both amphipathic
and nonamphipathic peptides crossed cell-membranes [110].
Another report against the idea that amphipathicity is a key
feature for cell-membrane translocation is the case of the
analogue of pAntp, AP-2AL (RQIKIWFQAARMLWKK)
[111]. This derivative is more ordered in an α-helical
conformation, resulting in a more amphipathic peptide which
in turn leads to an increased lipid binding affinity. In contrast to
pAntp, AP-2AL is capable of provoking the leakage of calcein
from vesicles. Whereas AP-2AL translocates the phospholipid
bilayer and destabilises the inner part of it, pAntp stays on the
outer leaflet and it is not able to translocate. It has therefore been
hypothesised that the AP-2AL derivative, in contrast to pAntp,
crosses the cell-membrane by pore formation, and also that the
helical amphipathicity of AP-2AL does not correlate with the
characteristics of pAntp that cause its cellular uptake.
CPPs having secondary amphipathicity due to polyproline II
structure include SAP, Tat(48–61) and agents based on a
polyproline helix scaffold. In the case of SAP, a 50% proline-
content leads to a PP II structure of 3.0 residues per turn [78]. A
secondary amphipathic peptide can then be built by placing
hydrophobic residues on one side of the helix and hydrophilic
amino acids on the opposite face. Recently, it has been reported
that Tat(48–61) adopts a polyproline II (PPII) secondary
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residues are mainly positioned at one face of the helix and the
charged ones are pointing to the other side [112].
Finally, a series of agents based on a polyproline helix
scaffold have been proposed as efficient cell-penetrating vectors
[113]. Hydroxyproline monomers were functionalised by O-
alkylation with hydrophobic or cationic moieties. Afterwards,
amphipathic agents were synthesised taking into account the 3.0
residues per turn periodicity of the PP II helix, with one face of
the helix containing hydrophobic moieties and the other two
with cationic groups. After verifying by CD that these
molecules can adopt a PP II structure, they were tested as
intracellular delivery agents, proving to be highly efficient.
4. Relevance of CPP self-assembly
The majority of CPPs contain positively charged groups,
mainly guanidinium moieties, but also amino groups, as well as
hydrophobic groups. It has also been observed that the location
of these groups in the sequence is not trivial; the optimal
positioning being that which favours maximum amphipathicity
(primary or secondary), or a maximum level of separation
between polar and non-polar parts. It is also well known that
amphiphilic compounds have a high tendency to aggregate
when placed in water or hydrophilic solvents.
It thus follows that certain CPPs can self-assemble,
suggesting that CPPs can be internalised as monomers or
aggregates. Currently, no clear relationship between aggrega-
tion and internalisation has been established, and evidence of
aggregation has only been provided for some CPPs (Fig. 3).
The first article reporting that the third helix Antennapedia
Homeodomain translocates biological membranes [1] includes
an explanation of how the different peptides derived from its
sequence form aggregates in the presence of SDS. The authors
maintain that the peptides will behave in the same manner in a
lipid bilayer than in a cell membrane environment. Interestingly,
following internalisation into E15 rat embryos, the peptides
were recovered as multimeric complexes.Fig. 3. Alternative models for the internalisation of self-assembling CPPs wheWorking with a solution of biotinylated transportan and
using polyacrylamide electrophoresis, it was found that the
transportan molecules are assembled into different multimers,
wherein the dimeric form predominates. Taking into account
these results, the authors suggest that at concentrations of 1 μM
and higher, CPP binding to the cell membrane occurs in the
form of oligomers or micelles.
The importance of aggregate formation for efficient gene-
transfer has been described [114]. Peptides such as 46Δ8 (LAR-
LLARLLARLLARL) or Hel 11-7 (KLLKLLLKLWKKLLKLLK)
are able to form aggregates with DNA and also have the
ability to transfer DNA. In the case of 46Δ12, which is not
able to form aggregates, the transfection efficiency is poor
compared to that of peptides that form aggregates. Moreover,
aggregate formation prevents DNA degradation.
As for hCT(9–32), self-assembly of the natural human
calcitonin hormone has been described [115]. Fibril formation
was assessed by turbidimetry measurements and electron
microscopy, whereby large, helically organised fibrils of 8–17
nm in diameter were found.
Other CPPs, like Pep-1 or MAPs have also been reported to
form aggregates in solution [103].
4.1. Sweet arrow peptide
In 2004 our laboratory described a novel group of CPPs:
amphipathic Pro-rich peptides [78]. The principal advantages of
these compounds are non-cytotoxicity, non-viral origin and
high solubility in aqueous media. The discovery stemmed from
combining findings from two different research projects. Firstly,
it was known that the N-terminal Pro-rich repetitive domain of
γ-zein, (VHLPPP)8, can interact with PC (phospatidylcholine)
liposomes and form deposits on the liposome membrane [116].
Secondly, it had also been shown in our lab that a linear
polyproline peptide (Pro14) labelled with fluorescein at the N-
terminus could cross the membrane of NRK cells [117]. The
design was based on a minimum proline content of 50% in the
sequence, in order to conserve the 3.0 residues per turnre either the CPP monomer (1) or the CPP aggregate (2) are internalised.
Fig. 4. SAP formula and structure, showing amphipathic secondary structure.
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amphipathic helix could be formed by placing hydrophobic
residues at positions i/i+2, i+6/i+8, i+12/i+14…, hydrophilic
residues at i+1, i+7, i+13…, and prolines at the remaining
positions. In an analogy to the N-t domain of γ-zein, the
hydrophobic residues chosen were valine and leucine, yielding
the sequence (VXLPPP)n (Fig 4). The positively charged H, K
or R were selected as hydrophilic residues, and monomers,
dimers or trimers were synthesised (n=1–3). Measuring
internalisation in HeLa cells, the best candidate found was the
trimer with arginine residues, (VRLPPP)3. Due to its non-
cytotoxic character and its permeability through the cell
membrane, the CPP was named Sweet Arrow Peptide (SAP).
An interesting property of the γ-zein octamer sequence is
its strong tendency to aggregate, as shown by the CD spectra
dependence on concentration as well as by the fibrils
observed by AFM and TEM [118,119]. The fibrils are 20
(±2) nm wide up to 1000 nm long. The inner part of the
fibrils has cylindrical filaments 3 (±0.7) nm wide. The
proposed aggregation model is the formation of cylindrical
micelles due to hydrophobic and hydrophilic interactions. TheFig. 5. CD spectra of SAP at varying concentrations (c=growth of the fibril seems to be longitudinal (i.e., the
molecules are aligned in the direction of the fibril axis)
because fibril width has been shown to be independent of
molecule length. It is believed that the first micelles formed
have a diameter of 3 nm, and a secondary aggregation of
several cylindrical micelles follows, leading to the formation
of 20 nm fibrils. The first micelles are formed because of
hydrophobic interactions, by which non-polar residues are
positioned inside and polar residues are positioned outside.
The latter occurs during the second aggregation step to form
cylindrical micelles and requires counterions because ionic
interactions are taking place.
Thus, we set out to determine if the self-assembling pattern
was also present for SAP CPP. It was found that the CD
spectrum of (VRLPPP)3 is typical of a PP II secondary
structure, with an intense negative band at 203 nm. However,
at 25 °C it is not possible to see the weak positive band at 228
nm. Spectra at different concentrations exhibit a self-assembly
pattern typical of amphipathic peptides. Flexible peptides able
to adopt amphipathic secondary structures are in equilibrium
between disordered non-amphipathic and ordered amphipathic
structures. An increase in peptide concentration causes an
increase in aggregation, which in turn shifts the equilibrium
towards the ordered structure. This displacement can be
monitored using CD. In the case of (VRLPPP)3, increasing the
concentration from 5 to 50 μM enhances molar ellipticity,
most likely indicating that aggregation is occurring. From 50
to 100 μM, molar ellipticity remains constant, denoting that an
equilibrium state has been reached, wherein fibrils have
already been formed (Fig. 5). To visualise the aggregates
suggested by CD, drops of a 50 μM SAP aqueous solution
was freeze-fixed, freeze-dried and covered with Pt over a5–100 μM) in 10 mM aq. phosphate buffer at pH 7.
Fig. 6. Transmission electron microscopy image of the replica obtained after
freeze-fixation and freeze-drying of a 50 μM aqueous solution of SAP over an
uncoated coverslip.
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preservation of any supermolecular structure present in the
peptide solution. A concentration of 50 μM was chosen for
two reasons: it had been observed that the final aggregated
state is reached at this concentration, and also because it is the
concentration used in cell internalisation assays. TEM
micrographs of the replicas show fibrils of 16 (±3) nm width
and variable length (Fig. 6). Thus, we believe that the same
aggregation model of the octamer can be applied in the case of
SAP peptide (Fig. 7).
As with other self-assembling CPPs, the internalised species
(i.e., monomeric or oligomeric) have yet to be identified.Fig. 7. Proposed model for the SAP self-assemb5. Experimental part
5.1. Materials
Fmoc-Nα-protected amino acids were obtained from IRIS
Biotech GmbH (Germany). The 2-chlorotrityl chloride resin
was purchased from CBL-PATRAS (Greece). Coupling
reagents: Benzotriazol-1-yloxytris(pyrrolidino)phosphonium
hexafluorophosphate, PyBOP, was purchased from Novabio-
chem (Switzerland); 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetra-
methyluronium tetrafluoroborate (TBTU) was purchased from
Albatros Chem Inc. (Canada). Trifluoroacetic acid (TFA) was
purchased from Scharlab S.L.(Barcelona). Piperidine, dimethyl-
formamide (DMF), dichloromethane (DCM) and acetonitrile
were purchased from SDS (France). N,N-diisopropylethylamine
(DIEA) was obtained from Merck (Germany). Triisopropylsi-
lane (TIS) was obtained from Fluka (Switzerland).
5.2. Synthesis and chromatography
SAP was synthesised by solid phase synthesis using the 9-
fluorenylmethoxycarbonyl/tert-butyl (Fmoc/tBu) strategy. 2-
Chlorotrityl resin, Nα-Fmoc-protected amino acids (2 eq.)/
TBTU(2eq.) andDIEA(6eq.)wereused.Asprotectinggroup for
the side chain of Arg 2,2,4,6,7-pentamethyldihydrobenzofurane-
5-sulfonyl (Pbf) was used. The Fmoc protecting group was
cleaved by treatment with a solution of 20% piperidine in
DMF (2×10 min). For the incorporation on the growing
peptide-resin of the Fmoc-Arg(Pbf)-OH, the TBTU coupling
reagent was replaced by the more potent phosphonium salt
PyBOP (2 eq.) and it was pre-activated for 10 min prior to the
addition of the amino acid to the peptide-resin.
SAP was cleaved from the resin by treatment with 95% TFA,
2.5% TIS, 2.5% water for 1h and identified at λ=443 nm by
analytical RP-HPLC [Waters 996 photodiode array detector
equipped with the Waters 2695 separation module, thely (i.e., formation of cylindrical micelles).
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Millenium software; Flow=1 ml/min; Gradient=5–100%B in
15 min (A=0.045% TFA in H2O, B=0.036% TFA in
acetonitrile)]. The purification was done in a semipreparative
RP-HPLC [Waters 2487 Dual λ Absorbance Detector equipped
with a Waters 2700 Sample Manager, a Waters 600 Controller, a
Waters Fraction Collector, a Symmetry® column (C18, 5 μm,
30×100 mm) and a Millenium chromatography manager
software; Flow=10 ml/min. Gradient=5–20%D in 5 min;
20–70%D in 30 min; 70–100%D in 5 min (D=0.1% TFA in
acetonitrile)]. SAP was characterised by MALDI-TOF mass
spectrometry (Vogayer-DE RP MALDI-TOF, PE Biosystems
with a N2 laser of 337 nm).
5.3. Circular dichroism
Circular dichroism spectra were recorded with a Jasco 810
UV-Vis spectropolarimeter, a Peltier CDF 426S/426L and a
temperature control JULABO F25 programm. The spectra were
obtained in a wavelength range of 190–250 nm at a spectral
bandwidth of 1 nm, with a time response of 4 s, a scan speed of
10 nm/min and a step resolution of 0.1 nm. Each spectrum was
the average of three accumulations. Spectra were measured at
concentrations ranging from 5 μM to 100 μM of peptide solved
in 10 mM phosphate buffer at pH and were recorded at 25 °C.
The blank was subtracted from each peptide spectrum. Molar
ellipticity is expressed per decimal residue.
5.4. Transmission electron microscopy (TEM)
Drops of aqueous samples of the peptides at 50 μM
concentration were deposited over uncoated cover slips.
Cover slips were freeze-fixed by projection against a copper
block cooled by liquid nitrogen (−196 °C) using a Cryoblock
(Reichert-Jung, Leica, Germany). The frozen samples were
stored at −196 °C in liquid nitrogen until subsequent use.
Samples were freeze-dried at −90 °C and coated with platinum
and carbon using a freeze-etching unit (model BAF-060, BAL-
TEC, Liechstenstein). A rotatory shadowing of the exposed
surface was made evaporating 1 nm platinum-carbon at an angle
of 6° above the horizontal, followed by 10 nm of carbon
evaporated at a 90° angle. The replica was separated from the
cover slip by immersion in concentrated hydrofluoric acid,
washed twice in distilled water and digested with 5% (v/v)
sodium hypochlorite for 5–10 min. The replicas were washed
several times in distilled water and collected on Formvar-coated
copper grids for electron microscopy. All electron micrographs
were obtained using a Jeol JEM 800 MT electron microscope
(Japan) operating at 80 KV. Images were obtained on a CCD
camera Megaview III (ISIS), Münster, Germany. Three samples
were prepared following the sample procedure and results
obtained by TEM imaging were reproducible.
6. Concluding remarks
In summary, we have seen that CPPs share properties and
how these properties may be related to specific steps of thevarious mechanisms of cellular internalisation. Thus, positive
charges are first used to interact with sulphates, carboxylates
and phosphates of the extracellular matrix. Hydrophobicity
enables a CPP to bind more tightly to a cell membrane, or to
penetrate a bilayer and achieve endosomal release. Moreover,
cationic and hydrophobic residues in CPPs are positioned for
maximal separation, often leading to amphipathicity. Lastly,
many CPPs are known to self-assemble, however, the role of
this property in cellular uptake remains to be elucidated.
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